Conflict of interest policies at Canadian Universities: Clarity and content

Journal of Academic Ethics

Volumn 6, Issue 1, 2008, Pages 79-90

  Williams Jones, Bryn ^a   MacDonald, Chris ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b SAINT MARY S UNIVERSITY   (Canada)

Author keywords

Canada; Conflict of interest; Ethics; G13; Policy; Professors; Readability; University

Indexed keywords

EID: 40849120688     PISSN: 15701727     EISSN: 15728544     Source Type: Journal    
DOI: 10.1007/s10805-007-9052-6     Document Type: Article

References (37)

1. Agres, T. (2003). The fruits of university research. The Scientist, 17(14), 55-56.
2. Angell, M. (2004). The truth about the drug companies: How they deceive us and what to do about it. New York: Random House.
3. Baird, P. A. (2003). Getting it right: industry sponsorship and medical research. Canadian Medical Association Journal, 168(10), 1267-1269.
4. Behrman, J. N. (2001). Adequacy of international codes of behavior. Journal of Business Ethics, 31(1), 51-64.
5. Bok, D. (2003). Universities in the marketplace: The commercialization of higher education. Princeton: Princeton University Press.
6. Boo, E. H. Y., & Koh, H. C. (2001). The influence of organizational and code-supporting variables on the effectiveness of a code of ethics. Teaching Business Ethics, 5(4), 357-373.
7. Boyd, E. A., Lipton, S., & Bero, L. A. (2004). Implementation of financial disclosure policies to manage conflicts of interest. Health Affairs, 23(2), 206-214.
8. Burgess, M. M. (2001). Beyond consent: ethical and social issues in genetic testing. Nature Reviews: Genetics, 2(2), 147-152.
9. Canadian Association of University Teachers. (2006). CAUT Almanac of Post-Secondary Education 2006 (Ottawa: Canadian Association of University Teachers), retrieved February 28, 2007 from ( http://www.caut.ca/en/ publications/almanac/default.asp ).
10. Cho, M. K., Shohara, R., Schissel, A., & Rennie, D. (2000). Policies on faculty conflicts of interest at US universities. JAMA: Journal of the American Medical Association, 284, 2203-2208.
11. Cohen, J. J. (2002). Managing financial conflicts of interest in clinical research. Science and Engineering Ethics, 8(3), 401-406.
12. Corrigan, O. P. (2003). Empty ethics: The problem with informed consent. Sociology of Health and Illness, 25(7), 768-792.
13. David, P. A. (2000). A tragedy of the public knowledge 'commons'? Global science, intellectual property and the digital technology boomerang. Electronic Journal of Intellectual Property Rights WP 04:1-34, ( http://www.oiprc.ox.ac.uk/ EJWP0400.pdf ).
14. Davis, M., & Stark, A., (eds.) (2001). Conflict of interest in the professions. New York, NY: Oxford University Press).
15. Dunne, C., & Warren, C. (1998). Lethal autonomy: The malfunction of the informed consent mechanism within the context of prenatal diagnosis of genetic variants. Issues in Law & Medicine, 14(2), 165-202.
16. Etzkowitz, H., Webster, A., Gebhardt, C., & Cantisano Terra, B. R. (2000). The future of the university and the university of the future: Evolution of ivory tower to entrepreneurial paradigm. Research Policy, 29, 313-330.
17. Fersko, R. S., & Merabet, H. (2004). Sponsored research and the public's right to know. Drug Development Research, 63(3), 103-111.
18. Fisher, D., & Atkinson-Grosjean, J. (2002). Brokers on the boundary: Academy-industry liaison in Canadian universities. Higher Education, 44(3-4), 449-467.
19. Gallagher, D. J., & Thompson, G. R. (1981). A Readability analysis of selected introductory economics textbooks. The Journal of Economic Education, 12(2), 60-63.
20. Johns, M. M. E., Barnes, M., & Florencio, P. S. (2003). Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest: Promoting research while maintaining trust. Journal of the American Medical Association, 289(6), 741-746.
21. Juicy Studio. (2007) Readability test. Retrieved May 5 from ( http://juicystudio.com/services/readability.php ).
22. Krimsky, S., Rothenberg, L. S., Stott, P., & Kyle, G. (1999). Scientific journals and their author's financial interests: A pilot study. In T.A. Caulfield, & B. Williams-Jones (Eds.) The commercialization of genetics research: Ethical, legal, and policy issues (pp. 101-110). New York, NY: Kluwer.
23. Lewis, S., Baird, P. A., Evans, R. G., et al. (2001). Dancing with the porcupine: Rules for governing the university-industry relationship [Commentary]. Canadian Medical Association Journal, 165(6), 783-785.
24. Lipton, S., Boyd, E. A., & Bero, L. A. (2004). Conflicts of interest in academic research: Policies, processes, and attitudes. Accountability in Research: Policies and Quality Assurance, 11(2), 83-102.
25. MacDonald, C., McDonald, M., & Norman, W. (2002). Charitable conflicts of interest. Journal of Business Ethics, 39(1-2), 67-74.
26. Nathan, D. G., & Weatherall, D. J. (2002). Academic freedom in clinical research. New England Journal of Medicine, 347(17), 1368-1371.
27. Paasche-Orlow, M. K., Taylor, H. A., & Brancati, F. L. (2003). Readability standards for informed-consent forms as compared with actual readability. New England Journal of Medicine, 348(8), 721-726.
28. Pressman, L. (2003). AUTM licensing survey: FY 2001. Northbrook, IL: AUTM.
29. Pressman, L., Burgess, R., Cook-Deegan, R. M., et al. (2006). The licensing of DNA patents by US academic institutions: An empirical survey. Nature Biotechnology, 24(1), 31-39.
30. Resnik, D. B. (1998). Conflicts of interest in science. Perspectives on Science, 6(4), 381-408.
31. Resnik, D. B., & Shamoo, A. E. (2002). Conflict of interest and the university. Accountability in Research, 9(1), 45-64.
32. Royal Society. (2003). Keeping science open: The effects of intellectual property policy on the conduct of science (London: Royal Society). ( http://www.royalsoc.ac.uk/document.asp?tip=0&id=1374 ).
33. Schafer, A. (2004). Biomedical conflicts of interest: A defence of the sequestration thesis-learning from the cases of Nancy Olivieri and David Healy. Journal of Medical Ethics, 30(1), 8-24.
34. Stein, C. M. (2004). Publishing work sponsored by the tobacco industry. Clinical Pharmacology & Therapeutics, 76(6), 517-518.
35. Stevens, B., Stevens, B. (2007). Corporate ethical codes: Effective instruments for influencing behavior. Journal of Business Ethics (in press) DOI 10.1007/s10551-007-9370-z.
36. Wilson, F. L., Baker, L. M., Brown-Syed, C., & Gollop, C. (2000). An analysis of the readability and cultural sensitivity of information on the National Cancer Institute's Web site: CancerNet. Oncology Nursing Forum, 27(9), 1403-1409.
37. Zakaluk, B. L., & Samuels, S. J. (1988). Readability: It's past, present, and future. Newark, DE: International Reading Association.